Actiq and Clopidogrel drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actiq and Clopidogrel. Common interactions include hypocalcaemia among females and acute myocardial infarction among males.

The phase IV clinical study analyzes what interactions people who take Actiq and Clopidogrel have. It is created by eHealthMe based on reports of 6 people who take Actiq and Clopidogrel from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 26, 2023

6 people who take Actiq and Clopidogrel together, and have interactions are studied.

What is Actiq?

Actiq has active ingredients of fentanyl citrate. It is often used in pain. eHealthMe is studying from 27,542 Actiq users for its effectiveness, alternative drugs and more.

What is Clopidogrel?

Clopidogrel has active ingredients of clopidogrel. It is often used in blood clots. eHealthMe is studying from 79,657 Clopidogrel users for its effectiveness, alternative drugs and more.

Number of Actiq and Clopidogrel reports submitted per year:

Common Actiq and Clopidogrel drug interactions by gender *:

female:

Hypocalcaemia
Hypokalaemia
Hypomagnesaemia

male:

Acute myocardial infarction
Cerebral artery thrombosis
Epicondylitis
Flank pain
Multimorbidity
Sputum discoloured
Cerebral infarction
Chest pain
Dyspnoea
Fall

Common Actiq and Clopidogrel drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Hypocalcaemia
Hypokalaemia
Hypomagnesaemia

60+:

Acute myocardial infarction
Cerebral artery thrombosis
Epicondylitis
Flank pain
Multimorbidity
Sputum discoloured
Cerebral infarction
Chest pain
Dyspnoea
Fall

* Approximation only. Some reports may have incomplete information.

Do you take Actiq and Clopidogrel?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lai SW, Lin CL, Liao KF, "Actively using clopidogrel correlates with an increased risk of acute pancreatitis in Taiwan", International journal of cardiology, 2015 Mar .
Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, "Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR)", InSeminars in thrombosis and hemostasis, 2012 Jan .
Frank P, "Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A Twenty-Year Review from the Southern Network on Adverse Reactions (SONAR)", , 2012 Jan .